ArticleNature communications2020

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.

Sejin Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.